High-dose therapy and autologous hematopoietic progenitor cells transplantation for relapsed or refractory hodgkin lymphoma: a follow up analysis of king hussein cancer center,results and prognostic variables

Introduction: High dose chemotherapy and autologous stem cell transplantation is a standard of care for patients with relapsed refractory Hodgkin's Lymphoma. Several factors including number of chemotherapy lines received before conditioning, time of relapse and remission status before transplantation can predict overall survival (OS) and progression free survival (PFS) in patients undergoing autologous stem cell transplantation.Abdel-Rahman et alreported on 63 patients, who underwent high dose chemotherapy followed by autologous stem cell transplantation at KHCC from 2003 to 2008.Here in , we report on the outcome of 86 patients, who underwent high dose chemotherapy and autologous HCT at single institution.